In the bustling market of women’s health and wellness, Joylux has carved out a niche with its innovative approach to non-invasive health solutions. At a time when awareness and advocacy for women’s health are at an all-time high, Joylux’s mission to empower women through revolutionary technology stands out. This comprehensive review delves into the essence of Joylux, exploring its products, the science…
Last week our webinar on innovation in menopause took place. If you missed it, don’t you worry – we’ve got you your back! In today’s brief we share a short overview of the key trends and talking points from the event with you, want to share our insights where the menopause market is going and why now is a great time to build or invest in those building…
Joi Women’s Wellness (Joi), a new femtech company, has launched in the US. The offering incluses hormone optimization and peptide therapy treatments available through a telehealth platform that is personalized and goal-based. Joi aims to provide a comprehensive approach to women’s healthcare that addresses the root causes of symptoms and creates customized treatment plans. Joi offers personalized coaching and treatments that are…
Ovia Health, the digital health platform for women and families, has announced the expansion of its Ovia app to include menopause symptom tracking and resources to support women during menopause. Ovia’s application is available to consumers and through its enterprise offerings for employers and health plans. The app provides educational content on symptoms, natural and medical treatment options, and tips on how…
Lifepoint Health and Midi Health have announced a collaboration to provide virtual care to women across the US who are experiencing symptoms of perimenopause and menopause. The partnership aims to improve the quality of care for this segment of women’s health by using telemedicine to serve patients in Lifepoint’s facilities. This will make high-quality virtual care accessible to thousands of women across…
Madorra has developed a non-invasive, home-use therapeutic ultrasound device that can potentially treat vaginal dryness in postmenopausal women with vulvovaginal atrophy (VVA). This condition affects millions of women in the US and is a component of genitourinary syndrome of menopause (GSM). Madorra’s Pilot 1 clinical study, which was published in Menopause, the Journal of the North American Menopause Society (NAMS), showed that…
Astellas Pharma has purchased a 30-second commercial during Super Bowl LVII to raise awareness about vasomotor symptoms (VMS), which are hot flashes and night sweats associated with menopause. The commercial features actress Carmella Riley asking women on the street about their experiences with VMS. Astellas has a new drug called fezolinetant in the works which treats moderate-to-severe VMS symptoms and has been…
The Berlin-based femtech company XbyX – Women in Balance, founded in 2019 by Peggy Reichelt and Monique Leonhardt, is a D2C platform for women in midlife offering scientifically founded, holistic solutions for menopause and healthy aging. After growing its customer base to over 50,000 women and doubling its revenue in 2022, the company has now announced a 7-figure pre-series A financing round,…
